Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies (Q36490167)

14 August 2017

1 reference

title

Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies (English)

1 reference

14 August 2017

1 reference

López-Pedrera C

1

1 reference

14 August 2017

Barbarroja N

2

1 reference

14 August 2017

Dorado G

3

1 reference

14 August 2017

Siendones E

4

1 reference

14 August 2017

Velasco F

5

1 reference

14 August 2017

publication date

25 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

20

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

1331-1340

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404264

14 August 2017

exact match

0 references

cites work

Cell biology of tissue factor, an unusual member of the cytokine receptor family.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Thrombin signalling and protease-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

The blood coagulation mechanism in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

The hemostatic system as a regulator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Regulation of angiogenesis by tissue factor cytoplasmic domain signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Cross-talk of integrin alpha3beta1 and tissue factor in cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Angiogenesis in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Antiangiogenic therapy in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Vascular endothelial growth factor and its receptors in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Oncogenes and angiogenesis: signaling three-dimensional tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappaB nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Constitutive NF-κB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Stratification of acute myeloid leukemia based on gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Changes in the proteome associated with the action of Bcr-Abl tyrosine kinase are not related to transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Proteomic analysis of transcription factor interactions in myeloid stem cell development and leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Proteomic analysis of the cellular proteins induced by adaptive concentrations of hydrogen peroxide in human U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Catalase regulates cell growth in HL60 human promyelocytic cells: evidence for growth regulation by H(2)O(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

The annexin protein lipocortin 1 regulates the MAPK/ERK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Angiogenesis in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Future directions in haematology: beyond multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Arsenic trioxide in multiple myeloma: rationale and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

7 January 2021

Haemostatic abnormalities and thrombotic disorders in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

7 January 2021

On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

7 January 2021

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

7 January 2021

New Developments in the Therapy of Acute Myelocytic Leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404264

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404264

1 reference

Dimensions Publication ID

14 August 2017

1004785480

0 references

1 reference